Medtronic Minimed, Inc.
Clinical trials sponsored by Medtronic Minimed, Inc., explained in plain language.
-
New insulin system aims to improve blood sugar control in type 1 diabetes
Disease control Not yet recruitingThis study will test a new automated insulin delivery system (NMX8) in 230 adults with type 1 diabetes whose blood sugar is not well controlled with their current system. Participants will use either the new NMX8 system or another approved system for a period, and researchers wil…
Phase: NA • Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Apr 26, 2026 17:09 UTC
-
New insulin pump aims to make diabetes management easier
Disease control Not yet recruitingThis study will test a new experimental insulin delivery system (NMX8) in 116 people with type 1 or type 2 diabetes who need insulin. The goal is to see if the new system is as safe and effective as the current Medtronic 780G system at keeping blood sugar in a healthy range. Part…
Phase: NA • Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Apr 26, 2026 17:06 UTC